Simplex Trading
CTXR icon

Simplex Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Simplex Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-624
Closed -$7K – 8675
2024
Q3 		$7K Buy
+624
New +$10.5K ﹤0.01% 7409
2024
Q1 		– Sell
-808
Closed -$15K – 8993
2023
Q4 		$15K Sell
808
-1,032
-56% -$19.6K ﹤0.01% 7126
2023
Q3 		$31K Sell
1,840
-5,776
-76% -$137K ﹤0.01% 6220
2023
Q2 		$228K Buy
7,616
+840
+12% +$27.6K ﹤0.01% 4154
2023
Q1 		$198K Sell
6,776
-5,200
-43% -$150K ﹤0.01% 4330
2022
Q4 		$236K Sell
11,976
-608
-5% -$16.6K ﹤0.01% 4022
2022
Q3 		$380K Buy
12,584
+5,316
+73% +$146K ﹤0.01% 3793
2022
Q2 		$167K Sell
7,268
-148
-2% -$4.06K ﹤0.01% 4847
2022
Q1 		$331K Buy
7,416
+5,576
+303% +$220K ﹤0.01% 4395
2021
Q4 		$70K Buy
1,840
+1,804
+5,011% +$81.8K ﹤0.01% 6778
2021
Q3 		$2K Buy
+36
New +$1.81K ﹤0.01% 9510

Other funds holding CTXR

HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Simplex Trading's CTXR Position: Q4 2025 in Review

Simplex Trading sold out of Citius Pharmaceuticals (CTXR) in Q4 2025, closing a stake of 9,556 shares — an estimated $11K sold.

Simplex Trading first reported a position in CTXR in Q3 2021 and held it in 12 quarters. The position peaked at $62K in Q3 2021. 39 funds tracked by Wall St. Rank hold CTXR as of Q4 2025.

  • Simplex Trading reported no remaining Citius Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 9,556 Citius Pharmaceuticals shares in Q4 2025, an estimated $11K.
  • Simplex Trading first reported a position in Citius Pharmaceuticals in Q3 2021 and held it in 12 quarters.
  • Simplex Trading's Citius Pharmaceuticals position peaked at $62K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.